Me's sale to Regeneron transfers genetic data for drug development, raising privacy issues and concerns over consumer control ...

Tarrytown-based Regeneron Pharmaceuticals, Inc. has announced it has been named the successful bidder in the bankruptcy ...

Republican senators John Cornyn and Chuck Grassley and Democratic Sen. Amy Klobuchar are rolling out a bipartisan measure to ...

Regeneron Pharmaceuticals has announced that it will be acquiring human genetics and biotechnology company 23andMe for $256m.

Successful trial results in the next few years could save thousands of lives and generate billions in new annual revenue for ...

We recently published a list of Jim Cramer Reveals “Quiet” Stock That Goes Up In This List Of 12 Stocks. In this article, we ...

We recently published a list of Jim Cramer Reveals “Quiet” Stock That Goes Up In This List Of 12 Stocks. In this article, we ...

There is nothing more inherently unique and personal to an individual than his or her DNA. Unlike many other types of personal information, a ...

The $8-per-share deal will give Sanofi control of Vigil's VG-3927, an oral drug candidate for Alzheimer's that acts as an ...

After more than five decades of legal disputes, international pressure, and human rights campaigns, the United Kingdom has ...